Show simple item record

Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice

dc.contributor.authorGarcía-Yébenes, Isaac
dc.contributor.authorGarcía-Culebras, Alicia
dc.contributor.authorPeña-Martínez, Carolina
dc.contributor.authorFernández-López, David
dc.contributor.authorDíaz-Guzmán, Jaime
dc.contributor.authorNegredo, Pilar
dc.contributor.authorAvendaño, Carlos
dc.contributor.authorCastellanos, Mar
dc.contributor.authorGasull, Teresa
dc.contributor.authorDávalos, Antoni
dc.contributor.authorMoro, María
dc.contributor.authorLizasoain, Ignacio
dc.date.accessioned2024-01-30T08:57:14Z
dc.date.available2024-01-30T08:57:14Z
dc.date.issued2018-06-13
dc.identifier.citationGarcía-Yébenes I, García-Culebras A, Peña-Martínez C, Fernández-López D, Díaz-Guzmán J, Negredo P, Avendaño C, Castellanos M, Gasull T, Dávalos A, Moro MA, Lizasoain I. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice. Stroke. 2018 Sep;49(9):2163-2172. doi: 10.1161/STROKEAHA.118.021540. PMID: 30018160.es
dc.identifier.urihttps://hdl.handle.net/10115/29173
dc.description.abstractBackground and Purpose—Recanalization with tPA (tissue-type plasminogen activator) is the only pharmacological therapy available for patients with ischemic stroke. However, the percentage of patients who may receive this therapy is limited by the risk of hemorrhagic transformation (HT)—the main complication of ischemic stroke. Our aim is to establish whether iron overload affects HT risk, to identify mechanisms that could help to select patients and to prevent this devastating complication. Methods—Mice fed with control or high-iron diet were subjected to thromboembolic stroke, with or without tPA therapy at different times after occlusion. Blood samples were collected for determination of malondialdehyde, matrix metalloproteinases, and fibronectin. Brain samples were collected 24 hours after occlusion to determine brain infarct and edema size, hemorrhage extension, IgG extravasation, and inflammatory and oxidative markers (neutrophil infiltration, 4-hydroxynonenal, and matrix metalloproteinase-9 staining). Results—Despite an increased rate of recanalization, iron-overload mice showed less neuroprotection after tPA administration. Importantly, iron overload exacerbated the risk of HT after early tPA administration, accelerated ischemia-induced serum matrix metalloproteinase-9 increase, and enhanced basal serum lipid peroxidation. High iron increased brain lipid peroxidation at most times and neutrophil infiltration at the latest time studied. Conclusions—Our data showing that iron overload increases the death of the compromised tissues, accelerates the time of tPA-induced reperfusion, and exacerbates the risk of HT may have relevant clinical implications for a safer thrombolysis. Patients with stroke with iron overload might be at high risk of HT after fibrinolysis, and, therefore, clinical studies must be performed to confirm our results.es
dc.language.isoenges
dc.subjectBlood-brain barrieres
dc.subjectfibrinolysises
dc.subjecthemorrhagees
dc.subjecthumanes
dc.subjectirones
dc.titleIron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Micees
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.1161/STROKEAHA.118.021540es
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccesses


Files in this item

This item appears in the following Collection(s)

Show simple item record

Los ítems de digital-BURJC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario